Ironwood Financial’s Defiance Nasdaq Junior Biotechnology ETF IBBJ Stock Holding History

Ironwood Financial’s Portfolio IBBJ Stock Details IBBJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-980	Closed	-$29K	–	605
2021 Q3	$29K	Hold	980	–	–	0.01%	244
2021 Q2	$32K	Hold	980	–	–	0.01%	231
2021 Q1	$33K	Buy	980 +260	+36%	+$9.44K	0.01%	213
2020 Q4	$25K	Buy	+720	New	+$22.1K	0.01%	220

Ironwood Financial's IBBJ Position: Q4 2021 in Review

Ironwood Financial sold out of Defiance Nasdaq Junior Biotechnology ETF (IBBJ) in Q4 2021, closing a stake of 980 shares — an estimated $29K sold.

Ironwood Financial first reported a position in IBBJ in Q4 2020 and held it in 4 quarters. The position peaked at $33K in Q1 2021. 0 funds tracked by Wall St. Rank hold IBBJ as of Q4 2021.

Ironwood Financial reported no remaining Defiance Nasdaq Junior Biotechnology ETF position as of Q4 2021 after selling out during the quarter.
Ironwood Financial sold 980 Defiance Nasdaq Junior Biotechnology ETF shares in Q4 2021, an estimated $29K.
Ironwood Financial first reported a position in Defiance Nasdaq Junior Biotechnology ETF in Q4 2020 and held it in 4 quarters.
Ironwood Financial's Defiance Nasdaq Junior Biotechnology ETF position peaked at $33K in Q1 2021.
0 funds tracked by Wall St. Rank held Defiance Nasdaq Junior Biotechnology ETF as of Q4 2021.

Based on Ironwood Financial's 13F filing for Q4 2021, filed 28 Jan 2022.